Last reviewed · How we verify
placebo eye drops — Competitive Intelligence Brief
marketed
Ophthalmology
Small molecule
Live · refreshed every 30 min
Target snapshot
placebo eye drops (placebo eye drops) — Allergan. Placebo eye drops contain no active pharmaceutical ingredient and produce therapeutic effects solely through the placebo effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| placebo eye drops TARGET | placebo eye drops | Allergan | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- placebo eye drops CI watch — RSS
- placebo eye drops CI watch — Atom
- placebo eye drops CI watch — JSON
- placebo eye drops alone — RSS
Cite this brief
Drug Landscape (2026). placebo eye drops — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-eye-drops. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing